Tata 1mg – an Unreasonable company

$ 10.99 · 4.6 (419) · In stock

India's leading mobile healthcare platform empowering Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price

Tata 1mg business model explained in detail

Tata 1MG's growth prescription

Tata 1mg FY22 revenue up 66 pc to Rs 222 cr; net loss narrows to Rs 146 cr - Industry News

Tata 1mg – an Unreasonable company

App Store 上的“Tata 1mg - Healthcare App”

Tata 1MG's growth prescription

Tata 1mg business model explained in detail

Tata 1mg - Raised $231M Funding from 39 investors - Tracxn

Tata Digital to acquire majority stake in online healthcare marketplace 1MG

Download TATA 1mg Online Healthcare App APK - LDPlayer

Tata 1mg for Doctors on the App Store

Tata 1mg – an Unreasonable company